ICB is directly invested in RMDY. CIB, ICB's parent company, is directly invested in BSP, BestBrain, and Wear2B.

Patients use BestBrain's personalized 

neurofeedback brain therapy to treat themselves at home with improved efficiency. BestBrain now runs clinical trials on early Alzheimer’s patients with key doctors.

Best Brain 

Revolutionizing mobile health.


BSP is dedicated to providing novel, non-invasive and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease.


RMDY’s SaaS platform powers Digital Therapeutics and patient engagement programs for leading healthcare organizations.